Comment on

• Evaluation of the efficacy and safety of dienogest in the treatment of painful symptoms in patients with adenomyosis: a randomized, double-blind, multicenter, placebo-controlled study.

  Osuga Y, Fujimoto-Okabe H, Hagino A. Osuga Y, et al. Fertil Steril. 2017 Oct;108(4):673-678. doi: 10.1016/j.fertnstert.2017.07.021. Epub 2017 Sep 11. Fertil Steril. 2017. PMID: 28911934 Clinical Trial.
• Prevalence of occult leiomyosarcomas and atypical leiomyomas after laparoscopic morcellation of leiomyomas in reproductive-age women.

  Pados G, Tsolakidis D, Theodoulidis V, Makedos A, Zaramboukas T, Tarlatzis B. Pados G, et al. Hum Reprod. 2017 Oct 1;32(10):2036-2041. doi: 10.1093/humrep/dex258. Hum Reprod. 2017. PMID: 28938732
• Long-term Results for Expectant Management of Ultrasonographically Diagnosed Benign Ovarian Teratomas.

  Pascual MA, Graupera B, Pedrero C, Rodriguez I, Ajossa S, Guerriero S, Alcázar JL. Pascual MA, et al. Obstet Gynecol. 2017 Dec;130(6):1244-1250. doi: 10.1097/AOG.0000000000002327. Obstet Gynecol. 2017. PMID: 29112653
• Contemporary Hormonal Contraception and the Risk of Breast Cancer.

  Mørch LS, Skovlund CW, Hannaford PC, Iversen L, Fielding S, Lidegaard Ø. Mørch LS, et al. N Engl J Med. 2017 Dec 7;377(23):2228-2239. doi: 10.1056/NEJMoa1700732. N Engl J Med. 2017. PMID: 29211679